Ido Laish Selected Research

ibuprofen-N-octyl-pyridostigmine

1/2006

Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ido Laish Research Topics

Disease

4	Inflammation (Inflammations) 01/2019 - 12/2005
4	Crohn Disease (Crohn's Disease) 01/2019 - 12/2012
3	Neoplasms (Cancer) 08/2021 - 10/2013
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2013 - 01/2011
3	Poisoning 01/2006 - 10/2005
2	Polyps 01/2022 - 12/2021
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 12/2021 - 08/2021
2	Non-alcoholic Fatty Liver Disease 01/2016 - 01/2011
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2015 - 12/2012
2	Obesity 10/2013 - 01/2011
2	Hypertension (High Blood Pressure) 10/2013 - 01/2011
2	Brain Diseases (Brain Disorder) 12/2012 - 10/2011
2	Blister (Bulla) 01/2006 - 12/2005
1	Carcinogenesis 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Adenocarcinoma 01/2022
1	Adenoma (Adenomas) 12/2021
1	Hereditary Breast and Ovarian Cancer Syndrome 08/2021
1	Adenomatous Polyps 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Ulcerative Colitis 08/2015
1	Colitis 10/2013
1	Sclerosing Cholangitis 10/2013
1	Fatty Liver 10/2013
1	Dyslipidemias (Dyslipidemia) 10/2013
1	Hepatitis 12/2012
1	Hyperplasia 12/2012
1	Portal Hypertension 12/2012
1	Insulin Resistance 05/2012
1	Liver Diseases (Liver Disease) 05/2012
1	Hypertriglyceridemia 01/2011
1	Brain Edema (Cerebral Edema) 01/2006
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2005

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2012
2	Syndecan-1 (Syndecan 1)IBA 01/2022 - 08/2015
2	CannabinoidsIBA 01/2018 - 01/2017
2	SomanIBA 01/2006 - 12/2005
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2006 - 12/2005
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	A-Form DNA (A-DNA)IBA 08/2021
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	resazurinIBA 01/2018
1	Coloring Agents (Dyes)IBA 01/2018
1	CannabidiolIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2016
1	C-Reactive ProteinIBA 08/2015
1	EnzymesIBA 10/2013
1	telomerase RNA (bTR)IBA 10/2013
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2013
1	Immunologic Factors (Immunomodulators)IBA 12/2012
1	Azathioprine (Imuran)FDA LinkGeneric 12/2012
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 12/2012
1	2-mercaptopurineIBA 12/2012
1	Fatty Acid-Binding ProteinsIBA 05/2012
1	Aspartic Acid (Aspartate)FDA Link 05/2012
1	SteroidsIBA 05/2012
1	AmmoniaIBA 10/2011
1	HDL CholesterolIBA 01/2011
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	Pharmaceutical PreparationsIBA 01/2006
1	ibuprofen-N-octyl-pyridostigmineIBA 01/2006
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2006
1	Mustard Gas (Sulfur Mustard)IBA 01/2006
1	Alkylating AgentsIBA 01/2006
1	ibuprofen-N-decyl-pyridostigmineIBA 01/2006
1	OximesIBA 12/2005
1	Atropine FDA LinkGeneric 12/2005
1	DioxinsIBA 10/2005

Therapy/Procedure

3	Liver Transplantation 10/2013 - 01/2011
2	Transplantation 10/2013 - 01/2011
1	Gastrectomy 01/2022
1	Therapeutics 12/2012